Cadila Healthcare surges on the bourses

09 Jul 2018 Evaluate

Cadila Healthcare is currently trading at Rs. 386.45, up by 4.75 points or 1.24% from its previous closing of Rs. 381.70 on the BSE.

The scrip opened at Rs. 395.00 and has touched a high and low of Rs. 395.00 and Rs. 384.55 respectively. So far 15822 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 1 has touched a 52 week high of Rs. 554.20 on 25-Jul-2017 and a 52 week low of Rs. 341.65 on 22-May-2018.

Last one week high and low of the scrip stood at Rs. 399.90 and Rs. 376.75 respectively. The current market cap of the company is Rs. 39076.26 crore.

The promoters holding in the company stood at 74.79%, while Institutions and Non-Institutions held 16.64% and 8.40% respectively.

Zydus Cadila has received the tentative approval from the US Food and Drug Administration (USFDA) to market Deferasirox Tablets for Oral Suspension (Exjade Tablets) in the strengths of 125 mg, 250 mg and 500 mg. It is used to treat ongoing high levels of iron in the body caused by multiple blood transfusions.

It is also used to treat high levels of iron in people with a certain blood disorder who do not require blood transfusions. It will be manufactured at the group’s manufacturing facility at SEZ, Ahmedabad. The estimated sale for Deferasirox Tablets is $ 150.3 million.

The group now has 202 approvals and has so far filed over 330 ANDAs since the commencement of the filing process in FY 2003-04.

Zydus Cadila is an innovative, global pharmaceutical company that discovers, develops, manufactures and markets a broad range of healthcare therapies.

Zydus Lifesciences Share Price

963.50 15.60 (1.65%)
29-Apr-2024 16:01 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1521.95
Dr. Reddys Lab 6279.95
Cipla 1407.55
Zydus Lifesciences 963.50
Lupin 1640.30
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.